These factors increase the risk of "long COVID" in children
More symptoms, older age, and longer hospitalization time increased the risk of post-COVID-19 conditions (long COVID) in children.
Novavax as a second dose: A potential game changer for adolescent COVID-19 vaccination
The findings showed that heterologous vaccination, or mixing different vaccines, was safe and effective, with the Novavax vaccine (NVX-CoV2373) providing enhanced protection against the Omicron variant.
How children transmitted COVID-19 within households
Following household COVID-19 transmissions for over 3 years, investigators found that 70.4% had a pediatric index case.
Impact of COVID-19 variants on symptom severity in infected children
The Omicron variant caused the most symptoms in pediatric patients. However, there were no differences in adverse outcomes by COVID-19 variant.
Booster vaccines for children: A key strategy to mitigate COVID-19 impact on schools and health
Accelerating bivalent booster vaccine campaigns for children could reduce pediatric hospitalizations and school absenteeism.
Do face masks actually protect children? A pediatric study of exhaled particles
This study determined the efficacy of face masks at reducing exhaled particles in children, as well as whether the type of activity affected the concentration and size of particles.
Safety and immunogenicity of the Novavax COVID-19 vaccine in adolescents
The vaccine efficacy of the Novavax’s NVX-CoV2373 was 79.5% in adolescents.
Children's COVID-19 symptoms, broken down by variant
Why are children’s COVID-19 vaccination rates so low?
This study surveyed parents’ opinions on the risks of COVID-19 infection versus vaccination to determine how they affected the decision to vaccinate a child against COVID-19.
Long COVID prevalence and severity in vaccinated versus unvaccinated children
Post-COVID-19 conditions were more common in unvaccinated children than in children who had received at least 1 dose of a COVID-19 vaccine.
Childhood asthma diagnoses halved during the COVID-19 pandemic
COVID-19 prevention practices such as masking, social distancing, and school closures lowered children’s exposures to circulating respiratory viruses and other environmental triggers of asthma.
Some young people have long COVID symptoms despite never contracting COVID-19
These findings suggest the World Health Organization's definition of post-COVID-19 condition (long COVID) may be too broad.
Catching a common cold gives children COVID-19 immunity
Exposure to a common seasonal coronavirus stimulates a memory T cell response that protects children against COVID-19. However, this immune response peaks at age 6.
Pediatric COVID-19 symptoms differed by variant
Communities with more racial prejudice have worse health outcomes
All studies included in this research found a correlation between area-level racial prejudice and adverse health outcomes among racial and ethnic minority populations.
Pfizer-BioNTech vaccine efficacy against Omicron in children 5-11 years
In children 5-11 years old, 2 doses of the Pfizer-BioNTech COVID-19 vaccine were moderately effective against documented, symptomatic Omicron infection.
FDA Cites Manufacturing Deficiencies in Second Complete Response Letter for Verrica’s VP-102
Verrica received a Complete Response Letter from the FDA regarding their New Drug Application for the topical molluscum contagiosum treatment, VP-102.
Self-tests for COVID-19 are accurate and tolerable for children
A comparison of COVID-19 PCR tests and rapid self-tests found self-tests to be highly accurate and user-friendly for children.
COVID-19 vaccine immune response in children with HIV
Children living with HIV had a similar immune response to mRNA COVID-19 vaccination as children without HIV.
Gestational age at COVID-19 vaccination affects baby’s antibodies
The higher the gestational age when pregnant women received a COVID-19 vaccine, the higher the serological titers at birth.
2 Clarke Drive Cranbury, NJ 08512